Abstract
The effects of compound Sophorae Flavescentis Jiechangrong capsule (CSFJC) on the expression of nuclear factor-κB p65 (NF-κB p65) and signal transducer and activator of transcription 6 (STAT6) in the intestinal mucosa of patients with ulcerative colitis and the possible mechanism were investigated. Eighteen patients with ulcerative colitis were randomly divided into a traditional Chinese medicine (TCM) group (n = 11) treated by CSFJC and a western medicine (WM) group (n = 7) treated by Sulfasalazine tablets. The treatment duration lasted eight weeks. Before and after the treatment, the symptoms and the physical signs were observed, and the routine stool test, the colonoscopy, and pathological examination were performed in the two groups. The expression levels of NF-κB p65 and STAT6 were detected by using immunohistochemistry. The results showed that the total effective rate of the curative effectiveness in TCM and WM groups was 100% and 71.4%, respectively, and the total effective rate of colonic mucosa lesion in TCM and WM groups was 90.9% and 71.4%, respectively, with the differences being significant (all P<0.05). The total effective rate of syndromes of damp-heat blocking according to the TCM in TCM and WM groups was 90.9% and 71.4%, respectively. After the treatment, the expression of NF-κB p65 and STAT6 in the two groups was decreased, and the decrease of NF-κB p65 and STAT6 expression in TCM group was more significant than in WM group (P<0.05). It was concluded that CSFJC can inhibit the activation and expression of NF-κB p65 and STAT6 in the intestinal mucosa of patients with ulcerative colitis, which is a possible mechanism for CSFJC treating ulcerative colitis.
Similar content being viewed by others
References
Ye R G, Lu Z Y. Internal Medicine. 6th ed. Beijing: People’s Health Press, 2004, 406–407 (in Chinese)
Fan H, Shou Z X, Lv J F, Shen L, Yang S L, Chen R. 11 cases of treatment of ulcerative colitis with Compound Sophorae Flavescentis Jiechangrong capsule. Zhong Guo Zhong Xi Yi Jie He Za Zhi, 2007, 15(1): 60–61 (in Chinese)
Zhou J P, Deng C S. Effect of Rosiglitazone on expression of NF-κB and ICAM-1 in the intestinal musoca of rats with ulcerative colitis. Shi Jie Hua Ren Xiao Hua Za Zhi, 2006, 14(1): 104–108 (in Chinese)
Gan H T, Chen Y Q, Ouyang Q. Sulfasalazine inhibits activation of nuclear factor-κB in patients with ulcerative colitis. J Gastroenterol Hepatol, 2005, 20(7): 1016–1024
Huang W C, Chen J J, Chen C C. c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression. J Biol Chem, 2003, 278(11): 9944–9952
Verma I M, Stevenson J K, Schwarz E M, Van Antwerp D, Miyamoto S. Rel/NF-κB/IκB family: Intimate tales of association and dissociation. Genes Dev, 1995, 9(22): 2723–2735
Ponnappan S, Cullen S J, Ponnappan U. Constitutive degradation of I kappa B alpha in human Tlymphocytes is mediated by calpain. Immun Ageing, 2005, 2: 15
Baldwin A S Jr. The NF-κB and IκB proteins: New discoveries and insights. Annu Rel Immunol, 1996, 14: 649–683
Bruns H A, Kaplan M H. The role of constitutively active Stat6 in leukemia and lymphoma. Crit Rev Oncol Hematol, 2006, 57(3): 245–253
Kraus J, Borner C, Hollt V. Distinct palindromic extensions of the 5′-TTC⋯GAA-3′ motif allow STAT6 binding in vivo. FASEB J, 2003, 17(2): 304–306
Fan H, Chen R, Shen L, Lv J F, Xiong P C, Shou Z X, Zhuang X. Oxymatrine Improves TNBS-induced Colitis in Rats by Inhibiting the Expression of NF-κB p65. J Huazhong Univ Sci Technol (Med Sci), 2008, 28(4): 415–420
Fan H, Duan X Y, Zhuang X, Lv J F, Shou Z X. Effect of Wumeiwan on NF-κBp65 in colon tissue of rats with ulcerative colitis. Shi Jie Hua Ren Xiao Hua Za Zhi, 2008, 16(8): 896–899 (in Chinese)
Baeuerle P A, Baltimore D. NF-κB: ten years after. Cell, 1996, 87(1): 13–20
Baeuerle P A, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol, 1994, 12: 141–179
Lv J F, Fan H, Shen L, Shou Z X, Zhuang X. Effects of Oxymatrine injection on expression of cytokines and nuclear factor-κB p65 in colonic intestinal mucosa of rats with experimental colitis. Shi Jie Hua Ren Xiao Hua Za Zhi, 2008, 16(20): 2289–2294 (in Chinese)
Gan H T, Ou Y Q, Chen Y Q, Xia Q J. Activation of nuclear factor-κB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis. Zhong Hua Yi Xue Za Zhi, 2002, 82(6): 384–388 (in Chinese)
Pang Y H, Zheng C Q, Ling B, Hu G Z, Zhang W J. The expression of signal transducer and activator of transcription 6 in the ulcerative colitis. Shi Jie Hua Ren Xiao Hua Za Zhi, 2004, 12(10): 2484–2486 (in Chinese)
Andresen L, Jørgensen V L, Perner A, Hansen A, Eugen-Olsen J, Rask-Madsen J. Activation of nuclear factor κB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut, 2005, 54(4): 503–509
Hanauer S B. Medical therapy for ulcerative colitis 2004. Gastroenterology, 2004, 126(6): 1582–1592
Abreu M T, Vora P, Faure E, Thomas L S, Arnold E T, Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated pro inflammatory gene expression in response to bacterial lipopolysaccharide. J immunol, 2001, 167(3): 1609–1616
Mitsuyama K, Suzuki A, Tomiyasu N, Takaki K, Toyonaga A, Sata M. Transcription factor-targeted therapies in inflammatory bowel disease. Digestion, 2001, 63(suppl 1): 68–72
Moynagh P N. The NF-κB pathway. J Cell Sci, 2005, 118(pt20): 4589–4592
Fan H, Qiu M Y, Mei J J, Shen G X, Liu S L, Chen R. Effects of four regulating intestines prescriptions on pathology and ultra structure of colon tissue in rats with ulcerative colitis. World J Gastroenterol, 2005, 11(31): 4800–4806
Fan H, Shen L, Tang Q, Xiong P C, Shou Z X, Liao Y, Liang L, Chen X Y. Effect of Wumeiwan on cytokines TNF-α, IL-6, IL-8, IL-10 and expression of NF-kB p65 in rats with ulceratine colitis. J Huazhong Uni Sci Technol (Med Sci), 2009; 29(5): 650–654
Zhu J, Guo L, Watson C J, Hu-Li J, Paul WE. Stat6 is necessary and sufficient for IL-4′s role in Th2 differentiation and cell expansion. J Immunol, 2001; 166(12): 7276–7281
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fan, H., Zhao, J., Shen, L. et al. Effect of compound Sophorae Flavescentis Jiechangrong capsule on expression of NF-κB p65 and STAT6 in the intestinal mucosa of patients with ulcerative colitis. Front. Med. China 3, 480–484 (2009). https://doi.org/10.1007/s11684-009-0083-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11684-009-0083-9